Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Drugs For Osteoarthritis Pain Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Drugs For Osteoarthritis Pain Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Drugs For Osteoarthritis Pain Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Drugs For Osteoarthritis Pain Market-Segmentation by Type
5.1 OTC
5.2 Prescription
6 Global Drugs For Osteoarthritis Pain Market-Segmentation by Application
6.1 Hospital
6.2 Clinics
6.3 Household
7 Global Drugs For Osteoarthritis Pain Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 AbbVie
8.1.1 AbbVie Profile
8.1.2 AbbVie Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 AbbVie Product/Solution Launches and Enhancements Analysis
8.1.4 AbbVie Business Overview/Recent Development/Acquisitions
8.2 Sanofi
8.2.1 Sanofi Profile
8.2.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Sanofi Product/Solution Launches and Enhancements Analysis
8.2.4 Sanofi Business Overview/Recent Development/Acquisitions
8.3 Daiichi Sankyo
8.3.1 Daiichi Sankyo Profile
8.3.2 Daiichi Sankyo Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Daiichi Sankyo Product/Solution Launches and Enhancements Analysis
8.3.4 Daiichi Sankyo Business Overview/Recent Development/Acquisitions
8.4 Cytori Therapeutics
8.4.1 Cytori Therapeutics Profile
8.4.2 Cytori Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Cytori Therapeutics Product/Solution Launches and Enhancements Analysis
8.4.4 Cytori Therapeutics Business Overview/Recent Development/Acquisitions
8.5 Iroko Pharmaceuticals
8.5.1 Iroko Pharmaceuticals Profile
8.5.2 Iroko Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Iroko Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.5.4 Iroko Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.6 Merck
8.6.1 Merck Profile
8.6.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Merck Product/Solution Launches and Enhancements Analysis
8.6.4 Merck Business Overview/Recent Development/Acquisitions
8.7 Afferent Pharmaceuticals
8.7.1 Afferent Pharmaceuticals Profile
8.7.2 Afferent Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Afferent Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.7.4 Afferent Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.8 Techfields Pharma
8.8.1 Techfields Pharma Profile
8.8.2 Techfields Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Techfields Pharma Product/Solution Launches and Enhancements Analysis
8.8.4 Techfields Pharma Business Overview/Recent Development/Acquisitions
8.9 Yooyoung Pharmaceutical
8.9.1 Yooyoung Pharmaceutical Profile
8.9.2 Yooyoung Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Yooyoung Pharmaceutical Product/Solution Launches and Enhancements Analysis
8.9.4 Yooyoung Pharmaceutical Business Overview/Recent Development/Acquisitions
8.10 SantoSolve
8.10.1 SantoSolve Profile
8.10.2 SantoSolve Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 SantoSolve Product/Solution Launches and Enhancements Analysis
8.10.4 SantoSolve Business Overview/Recent Development/Acquisitions
8.11 Horizon Pharma
8.11.1 Horizon Pharma Profile
8.11.2 Horizon Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Horizon Pharma Product/Solution Launches and Enhancements Analysis
8.11.4 Horizon Pharma Business Overview/Recent Development/Acquisitions
8.12 Winston Pharmaceuticals
8.12.1 Winston Pharmaceuticals Profile
8.12.2 Winston Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Winston Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.12.4 Winston Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.13 Novartis International
8.13.1 Novartis International Profile
8.13.2 Novartis International Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Novartis International Product/Solution Launches and Enhancements Analysis
8.13.4 Novartis International Business Overview/Recent Development/Acquisitions
8.14 Zynerba Pharmaceuticals
8.14.1 Zynerba Pharmaceuticals Profile
8.14.2 Zynerba Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Zynerba Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.14.4 Zynerba Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.15 Abiogen Pharma
8.15.1 Abiogen Pharma Profile
8.15.2 Abiogen Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Abiogen Pharma Product/Solution Launches and Enhancements Analysis
8.15.4 Abiogen Pharma Business Overview/Recent Development/Acquisitions
8.16 Abbott Laboratories
8.16.1 Abbott Laboratories Profile
8.16.2 Abbott Laboratories Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Abbott Laboratories Product/Solution Launches and Enhancements Analysis
8.16.4 Abbott Laboratories Business Overview/Recent Development/Acquisitions
8.17 BioDelivery Sciences International
8.17.1 BioDelivery Sciences International Profile
8.17.2 BioDelivery Sciences International Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 BioDelivery Sciences International Product/Solution Launches and Enhancements Analysis
8.17.4 BioDelivery Sciences International Business Overview/Recent Development/Acquisitions
8.18 CrystalGenomics
8.18.1 CrystalGenomics Profile
8.18.2 CrystalGenomics Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 CrystalGenomics Product/Solution Launches and Enhancements Analysis
8.18.4 CrystalGenomics Business Overview/Recent Development/Acquisitions
8.19 Endo Pharmaceuticals Holdings
8.19.1 Endo Pharmaceuticals Holdings Profile
8.19.2 Endo Pharmaceuticals Holdings Sales, Growth Rate and Global Market Share from 2015-2020
8.19.3 Endo Pharmaceuticals Holdings Product/Solution Launches and Enhancements Analysis
8.19.4 Endo Pharmaceuticals Holdings Business Overview/Recent Development/Acquisitions
8.20 ICeutica
8.20.1 ICeutica Profile
8.20.2 ICeutica Sales, Growth Rate and Global Market Share from 2015-2020
8.20.3 ICeutica Product/Solution Launches and Enhancements Analysis
8.20.4 ICeutica Business Overview/Recent Development/Acquisitions
8.21 Regeneron Pharmaceuticals
8.21.1 Regeneron Pharmaceuticals Profile
8.21.2 Regeneron Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.21.3 Regeneron Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.21.4 Regeneron Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.22 Johnson & Johnson
8.22.1 Johnson & Johnson Profile
8.22.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.22.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.22.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.23 Pfizer
8.23.1 Pfizer Profile
8.23.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.23.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.23.4 Pfizer Business Overview/Recent Development/Acquisitions
8.24 Nuvo Research
8.24.1 Nuvo Research Profile
8.24.2 Nuvo Research Sales, Growth Rate and Global Market Share from 2015-2020
8.24.3 Nuvo Research Product/Solution Launches and Enhancements Analysis
8.24.4 Nuvo Research Business Overview/Recent Development/Acquisitions
8.25 Astellas Pharma
8.25.1 Astellas Pharma Profile
8.25.2 Astellas Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.25.3 Astellas Pharma Product/Solution Launches and Enhancements Analysis
8.25.4 Astellas Pharma Business Overview/Recent Development/Acquisitions
8.26 Eli Lilly
8.26.1 Eli Lilly Profile
8.26.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
8.26.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
8.26.4 Eli Lilly Business Overview/Recent Development/Acquisitions
9 Global Drugs For Osteoarthritis Pain Market-Segmentation by Geography
10 North America
10.1 North America Drugs For Osteoarthritis Pain Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Drugs For Osteoarthritis Pain Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Drugs For Osteoarthritis Pain Production Analysis from 2015-2020
10.4 North America Drugs For Osteoarthritis Pain Consumption Analysis from 2015-2020
10.5 North America Drugs For Osteoarthritis Pain Import and Export from 2015-2020
10.6 North America Drugs For Osteoarthritis Pain Value, Production and Market Share by Type (2015-2020)
10.7 North America Drugs For Osteoarthritis Pain Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Drugs For Osteoarthritis Pain by Country (United States, Canada)
10.8.1 North America Drugs For Osteoarthritis Pain Sales by Country (2015-2020)
10.8.2 North America Drugs For Osteoarthritis Pain Consumption Value by Country (2015-2020)
10.9 North America Drugs For Osteoarthritis Pain Market PEST Analysis
11 Europe
11.1 Europe Drugs For Osteoarthritis Pain Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Drugs For Osteoarthritis Pain Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Drugs For Osteoarthritis Pain Production Analysis from 2015-2020
11.4 Europe Drugs For Osteoarthritis Pain Consumption Analysis from 2015-2020
11.5 Europe Drugs For Osteoarthritis Pain Import and Export from 2015-2020
11.6 Europe Drugs For Osteoarthritis Pain Value, Production and Market Share by Type (2015-2020)
11.7 Europe Drugs For Osteoarthritis Pain Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Drugs For Osteoarthritis Pain by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Drugs For Osteoarthritis Pain Sales by Country (2015-2020)
11.8.2 Europe Drugs For Osteoarthritis Pain Consumption Value by Country (2015-2020)
11.9 Europe Drugs For Osteoarthritis Pain Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Drugs For Osteoarthritis Pain Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Drugs For Osteoarthritis Pain Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Drugs For Osteoarthritis Pain Production Analysis from 2015-2020
12.4 Asia-Pacific Drugs For Osteoarthritis Pain Consumption Analysis from 2015-2020
12.5 Asia-Pacific Drugs For Osteoarthritis Pain Import and Export from 2015-2020
12.6 Asia-Pacific Drugs For Osteoarthritis Pain Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Drugs For Osteoarthritis Pain Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Drugs For Osteoarthritis Pain by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Drugs For Osteoarthritis Pain Sales by Country (2015-2020)
12.8.2 Asia-Pacific Drugs For Osteoarthritis Pain Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Drugs For Osteoarthritis Pain Market PEST Analysis
13 Latin America
13.1 Latin America Drugs For Osteoarthritis Pain Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Drugs For Osteoarthritis Pain Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Drugs For Osteoarthritis Pain Production Analysis from 2015-2020
13.4 Latin America Drugs For Osteoarthritis Pain Consumption Analysis from 2015-2020
13.5 Latin America Drugs For Osteoarthritis Pain Import and Export from 2015-2020
13.6 Latin America Drugs For Osteoarthritis Pain Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Drugs For Osteoarthritis Pain Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Drugs For Osteoarthritis Pain by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Drugs For Osteoarthritis Pain Sales by Country (2015-2020)
13.8.2 Latin America Drugs For Osteoarthritis Pain Consumption Value by Country (2015-2020)
13.9 Latin America Drugs For Osteoarthritis Pain Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Drugs For Osteoarthritis Pain Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Drugs For Osteoarthritis Pain Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Drugs For Osteoarthritis Pain Production Analysis from 2015-2020
14.4 Middle East & Africa Drugs For Osteoarthritis Pain Consumption Analysis from 2015-2020
14.5 Middle East & Africa Drugs For Osteoarthritis Pain Import and Export from 2015-2020
14.6 Middle East & Africa Drugs For Osteoarthritis Pain Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Drugs For Osteoarthritis Pain Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Drugs For Osteoarthritis Pain by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Drugs For Osteoarthritis Pain Sales by Country (2015-2020)
14.8.2 Middle East & Africa Drugs For Osteoarthritis Pain Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Drugs For Osteoarthritis Pain Market PEST Analysis
15 Future Forecast of the Global Drugs For Osteoarthritis Pain Market from 2020-2028
15.1 Future Forecast of the Global Drugs For Osteoarthritis Pain Market from 2020-2028 Segment by Region
15.2 Global Drugs For Osteoarthritis Pain Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Drugs For Osteoarthritis Pain Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
